Astron Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.21 Cr
- Satisfied Charges ₹ 2.50 M
- Revenue Growth -4.54%
- Profit Growth 1.20%
- Ebitda 23.92%
- Net Worth 23.54%
- Total Assets 24.88%
About Astron Pharmaceuticals
Astron Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 March 1989 and has a history of 35 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.21 Cr. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Pawan Goel, Sangita Goel, Satyam Goel, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1989PTC035303
-
Company No.
035303
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Mar 1989
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Astron Pharmaceuticals Private Limited offer?
Astron Pharmaceuticals Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs.
Who are the key members and board of directors at Astron Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Goel
|
Director | 02-Mar-1989 | Current |
|
Sangita Goel
|
Director | 02-Mar-1989 | Current |
|
Satyam Goel
|
Director | 25-Mar-2015 | Current |
|
Anuj Goel
|
Director | 25-Mar-2015 | Current |
Financial Performance of Astron Pharmaceuticals.
Astron Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.54% decrease. The company also saw a slight improvement in profitability, with a 1.2% increase in profit. The company's net worth Soared by an impressive increase of 23.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astron Pharmaceuticals?
Unlock access to Astron Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
V. N. Cranes Private LimitedAnuj Goel is a mutual person
-
Astron Plastochem Private LimitedPawan Goel and Sangita Goel are mutual person
-
Kountry Pharmacare Private Limited
Satyam Goel is a mutual person
-
Welpro (India) Private Limited
Anuj Goel is a mutual person
-
V.N. Overseas Private Limited
Anuj Goel is a mutual person
Charges (Loans)
₹22.10 M
₹2.50 M
Charges Breakdown by Lending Institutions
- Others : 2.20 Cr
- Canara Bank : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 May 2024 | Others | ₹2.00 Cr | Open |
| 10 May 2022 | Others | ₹2.00 M | Open |
| 07 Nov 2020 | Canara Bank | ₹0.10 M | Open |
| 21 Apr 2007 | Syndicate Bank | ₹2.50 M | Satisfied |
How Many Employees Work at Astron Pharmaceuticals?
Unlock and access historical data on people associated with Astron Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astron Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.